Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer.
Ahmed KA, Grass GD, Orman AG, Liveringhouse C, Montejo ME, Soliman HH, Han HS, Czerniecki BJ, Torres-Roca JF, Diaz R. Ahmed KA, et al. Among authors: diaz r. Int J Breast Cancer. 2018 Jun 10;2018:6729802. doi: 10.1155/2018/6729802. eCollection 2018. Int J Breast Cancer. 2018. PMID: 29984003 Free PMC article. Review.
Breast Reconstruction and Radiation Therapy.
Yun JH, Diaz R, Orman AG. Yun JH, et al. Among authors: diaz r. Cancer Control. 2018 Jan-Dec;25(1):1073274818795489. doi: 10.1177/1073274818795489. Cancer Control. 2018. PMID: 30132338 Free PMC article. Review.
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA. Figura NB, et al. Among authors: diaz r. Breast Cancer Res Treat. 2019 Jun;175(3):781-788. doi: 10.1007/s10549-019-05170-7. Epub 2019 Mar 11. Breast Cancer Res Treat. 2019. PMID: 30859348
Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
Ahmed KA, Liveringhouse CL, Mills MN, Figura NB, Grass GD, Washington IR, Harris EE, Czerniecki BJ, Blumencranz PW, Eschrich SA, Scott JG, Diaz R, Torres-Roca JF. Ahmed KA, et al. Among authors: diaz r. EBioMedicine. 2019 Sep;47:163-169. doi: 10.1016/j.ebiom.2019.08.019. Epub 2019 Aug 12. EBioMedicine. 2019. PMID: 31416721 Free PMC article.
The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.
Mills M, Liveringhouse C, Lee F, Nanda RH, Ahmed KA, Washington IR, Thapa R, Fridley BL, Blumencranz P, Extermann M, Loftus L, Balducci L, Diaz R. Mills M, et al. Among authors: diaz r. J Geriatr Oncol. 2021 Mar;12(2):219-226. doi: 10.1016/j.jgo.2020.08.007. Epub 2020 Aug 26. J Geriatr Oncol. 2021. PMID: 32859560 Free PMC article.
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity.
Weinfurtner RJ, Raghunand N, Stringfield O, Abdalah M, Niell BL, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Montejo M. Weinfurtner RJ, et al. Among authors: diaz r. Clin Breast Cancer. 2022 Feb;22(2):e214-e223. doi: 10.1016/j.clbc.2021.06.016. Epub 2021 Jul 20. Clin Breast Cancer. 2022. PMID: 34384695
2,299 results